In Medford, Oregon, a nurse has been arrested for
Post# of 148261
After we got the disappointing results for the CD12 trial, I mentioned one or two times that I thought it would be good practice in Cytodyn's trials to do some extra testing of trial patients to ensure they did or did not get their Leronlimab.
More effort, more expense and I don't know what the test would be but, in the middle of a pandemic with lots of people dying, who wouldn't want a drug that could save your life?
The kicker to the story was that a health expert said that it is typical for 10% of drugs in a hospital in regular times to be "diverted".
The suspected diversion of funds by Amarex and Pourhassen and the failure to correctly perform the trials was bad enough for us. But still some other "diversion" may have given us the crappy results we got from CD12.
How expensive are Receptor Occupancy tests anyway?